Search research articles
Contact Us
Filters
Showing results (561-570 of 633) with videos related to
Page
of 64
Sort By:
Journal of Neurosurgery. Spine
|
November 7, 2025
Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter?
Wee Loon Ong, Kang Liang Zeng, Daniel Moore-Palhares, et al.
Cancer Letters
|
December 3, 2014
Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo
Mao-Bin Meng, Huan-Huan Wang, Wen-Hao Guo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2022
Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy
K Liang Zeng, Sten Myrehaug, Hany Soliman, et al.
Frontiers in Immunology
|
May 27, 2022
Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology
Liang Zeng, Shu-Hua Li, Shuo-Yu Xu, et al.
Oncotarget
|
July 16, 2016
CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX
Wenting Jia, Caiping Ren, Lei Wang, et al.
Scientific Reports
|
July 2, 2025
The disrupted jet stream and its influence on flight time during solar proton events
Xiaoheng Xu, Yi Wang, Fengsi Wei, et al.
International Journal of Oncology
|
June 30, 2018
High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma
Chen Shi, Yongjun Guan, Liang Zeng, et al.
Heliyon
|
January 6, 2025
Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases
Liqun Li, Zhe Huang, Yangqian Chen, et al.
Cell Reports. Medicine
|
June 30, 2026
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial
Huan Yan, Wenjuan Jiang, Yi Xiong, et al.
Current Topics in Medicinal Chemistry
|
June 23, 2007
Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonists
Liang Zeng Yan, Hansen M Hsiung, Mark L Heiman, et al.
Page
of 64
Search research articles
Search
Showing results (561-570 of 633) with videos related to
Sort By:
Page
of 64
Journal of Neurosurgery. Spine
|
November 7, 2025
Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter?
Wee Loon Ong, Kang Liang Zeng, Daniel Moore-Palhares, et al.
Cancer Letters
|
December 3, 2014
Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo
Mao-Bin Meng, Huan-Huan Wang, Wen-Hao Guo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2022
Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy
K Liang Zeng, Sten Myrehaug, Hany Soliman, et al.
Frontiers in Immunology
|
May 27, 2022
Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology
Liang Zeng, Shu-Hua Li, Shuo-Yu Xu, et al.
Oncotarget
|
July 16, 2016
CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX
Wenting Jia, Caiping Ren, Lei Wang, et al.
Scientific Reports
|
July 2, 2025
The disrupted jet stream and its influence on flight time during solar proton events
Xiaoheng Xu, Yi Wang, Fengsi Wei, et al.
International Journal of Oncology
|
June 30, 2018
High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma
Chen Shi, Yongjun Guan, Liang Zeng, et al.
Heliyon
|
January 6, 2025
Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases
Liqun Li, Zhe Huang, Yangqian Chen, et al.
Cell Reports. Medicine
|
June 30, 2026
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial
Huan Yan, Wenjuan Jiang, Yi Xiong, et al.
Current Topics in Medicinal Chemistry
|
June 23, 2007
Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonists
Liang Zeng Yan, Hansen M Hsiung, Mark L Heiman, et al.
Page
of 64